首页> 外文期刊>Journal of Clinical Microbiology >Quantitative Detection of Hepatitis B Virus DNA in Two International Reference Plasma Preparations
【24h】

Quantitative Detection of Hepatitis B Virus DNA in Two International Reference Plasma Preparations

机译:两种国际参考血浆制剂中乙肝病毒DNA的定量检测

获取原文
           

摘要

Quantitative detection of hepatitis B virus (HBV) in serum or plasma is of significance for monitoring of therapy and establishment of the prognosis of the disease, as well as for infectivity assessment and quality control of the diagnosis. Unfortunately, various commercially available test kits for HBV DNA yielded conflicting quantitative results, with differences of up to a factor of 120. The Eurohep Pathobiology Group has established two reference samples of plasma from HBV carriers and determined as accurately as possible the number of HBV DNA molecules in these samples. Plasma donations from two single highly viremic carriers of HBV genotype A (HBV surface antigen subtype adw2) and genotype D (ayw2/3), respectively, were collected, and coded dilutions of these samples were analyzed by members of the Eurohep Pathobiology Group. Quantitative results from the seven laboratories reporting consistent results were initially divergent. Limiting dilution and nested PCR assays suffered from incomplete DNA extraction. Hybridization assays used inaccurately quantitated cloned DNA as a reference. Two hybridization assays could not be calibrated directly with cloned HBV DNA, because virion-derived DNA reacted much less efficiently. After identification and elimination of these problems, limiting-dilution assays from three laboratories and hybridization assays from two producers generated consistent and concordant results: 2.7 × 109 HBV DNA molecules/ml (range, 2.1 × 109 to 3.4 × 109 HBV DNA molecules/ml) in the plasma from the carrier of genotype A and 2.6 × 109 HBV DNA molecules/ml (range, 2.1 × 109 to 3.0 × 109 HBV DNA molecules/ml in the plasma from the carrier of genotype D. The two Eurohep reference plasma samples have already been used for the standardization of test kits and in quality control trials, and the plasma from the carrier of genotype A will probably be the basis of a World Health Organization reference sample.
机译:血清或血浆中乙型肝炎病毒(HBV)的定量检测对于监测治疗和确定疾病的预后以及对传染性评估和诊断质量控制具有重要意义。不幸的是,各种市售的HBV DNA检测试剂盒产生的定量结果相互矛盾,差异高达120倍。Eurohep病理生物学小组已经从HBV携带者中建立了两个血浆参考样品,并尽可能准确地确定了HBV DNA的数量。这些样品中的分子。分别收集了两个单独的HBV基因型A(HBV表面抗原亚型 adw2 )和基因型D( ayw2 / 3 )的高致病性携带者的血浆捐赠,并进行了稀释这些样品中的一部分由Eurohep病理生物学小组的成员进行了分析。来自七个报告一致结果的实验​​室的定量结果最初存在差异。极限稀释和巢式PCR检测法的DNA提取不完全。杂交测定使用了不准确定量的克隆DNA作为参考。不能直接用克隆的HBV DNA校准两种杂交试验,因为病毒体衍生的DNA反应效率低得多。在确定并消除了这些问题之后,三个实验室的限量稀释测定法和两个生产者的杂交测定法产生了一致且一致的结果:2.7×10 9 HBV DNA分子/ ml(范围为2.1×10 <血浆中来自基因型A和2.6×10 9 HBV DNA分子的载体中的sup> 9 至3.4×10 9 HBV DNA分子/ ml ml(基因型D携带者血浆中的HBV DNA分子/ ml(范围从2.1×10 9 到3.0×10 9 / ml)。这两个Eurohep参考血浆样品已经被用于测试试剂盒的标准化和质量控制试验中,来自基因型A携带者的血浆可能将成为世界卫生组织参考样品的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号